Correlation between self-reported adherence to highly active antiretroviral therapy (HAART) and virologic outcome
- 1 July 2001
- journal article
- research article
- Published by Springer Nature in Advances in Therapy
- Vol. 18 (4) , 163-173
- https://doi.org/10.1007/bf02850110
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Determinants of Heterogeneous Adherence to HIV-Antiretroviral Therapies in the Multicenter AIDS Cohort StudyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV InfectionAnnals of Internal Medicine, 2000
- Patient-Reported Nonadherence to HAART Is Related to Protease Inhibitor LevelsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence InstrumentsAIDS Care, 2000
- Efficacy, safety, and adherence with a twice-daily combination lamivudine/zidovudine tablet formulation, plus a protease inhibitor, in HIV infectionAIDS, 2000
- Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent populationAIDS, 2000
- Compliance issues in the treatment of HIV infectionAmerican Journal of Health-System Pharmacy, 1998
- Simultaneous vs Sequential Initiation of Therapy With Indinavir, Zidovudine, and Lamivudine for HIV-1 InfectionJAMA, 1998
- Public Health Implications of Antiretroviral Therapy and HIV Drug ResistanceJAMA, 1998
- A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or LessNew England Journal of Medicine, 1997